# FDA Warning Letter: Kimera Labs, Inc.
> 2024-01-04 · Division of Biological Products Operations I · `773f564a635910d0`
## Letter
- **Company:** Kimera Labs, Inc.
- **Posted Date:** 2024-01-04
- **Letter Issue Date:** 2023-09-01
- **Issuing Office:** Division of Biological Products Operations I
## Subject
Investigational Device Exemptions (IDE)
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*